Yngvi Bio ApS
Private limited companyCVR 45351335København NActive
Yngvi Bio ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2025. Equity was negative at the end of 2025 (−DKK 2m). The company is new and has been registered for 1 years. The latest net result (2025) was a loss of DKK 2m.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesManagement and owners, last 24 months
- New in management: Kenneth Veland Halberg (director, 23/01/2025), Eva Maria Rebrova (director, 23/01/2025) and Jarne Elleholm (chair of the board, 03/07/2025) (+3).
- New owners registered: Veland Halberg Holding ApS (23/01/2025) and EvaNova Holding ApS (23/01/2025).
Registrations, last 24 months
- 18/06/2025: Name changed from NanoGuard Crop Solutions ApS to Yngvi Bio ApS
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | −1,054 | – |
| Operating profit (EBIT) | −2,131 | – |
| Profit before tax | −2,298 | – |
| Net profit | −2,026 | – |
| Total assets | 2,973 | – |
| Equity | −1,986 | – |
| Liabilities | 4,960 | – |
| Cash and cash equivalents | 2,650 | – |
| Average number of employees | 2 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 2m at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 23/01/2025 – 31/12/2025 | 25/06/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 68,794of 69,742 Better than 1% | No. 68,232of 69,964 Better than 2% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 250of 323 Better than 23% | No. 271of 329 Better than 18% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,304of 16,614 Better than 2% | No. 16,219of 16,661 Better than 3% |
| All companies of type ApS66,508 companies in the comparison | No. 65,642of 66,379 Better than 1% | No. 64,770of 66,505 Better than 3% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- Yngvi Bio ApS−DKK 1.1m
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Yngvi Bio ApS−DKK 2m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- Yngvi Bio ApS−DKK 2m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- Yngvi Bio ApS4
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Veland Halberg Holding ApS50%
- EvaNova Holding ApS50%
Management
6 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Kenneth Veland Halberg | Director | 23/01/2025 |
| Eva Maria Rebrova | Director | 23/01/2025 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Jarne Elleholm | Chair of the board | 03/07/2025 |
| Benedicte Francoise Simone Flambard | Board member | 03/07/2025 |
| Kenneth Veland Halberg | Board member | 03/07/2025 |
| Eva Maria Rebrova | Board member | 03/07/2025 |
- Founders
- Veland Halberg Holding ApS, EvaNova Holding ApS
Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af en direktør i forening med et bestyrelsesmedlem.
Address and production units
1 active production unitsOle Maaløes Vej 3
2200 København N
København Municipality · Postcode 2200
Other companies at the address (8)
- BII Holdings A/SOther financial service activities n.e.c.
- Skape Bio ApSResearch and experimental development on natural sciences and engineering
- Agrobiomics ApSResearch and experimental development on natural sciences and engineering
- Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
- BioColor ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Yngvi Bio ApS | Ole Maaløes Vej 3, 2200 København N | 4 | 1031014383 |
Purpose
Selskabets formål er at drive forskning, udvikling, produktion og handel med bioteknologiske løsninger og produkter til afgrødebeskyttelse, sygdomsbekæmpelse og bæredygtigt landbrug samt drive virksomhed, der står i forbindelse hermed.
The purpose is quoted from the register in Danish.
Changes year by year
11 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
202510 changesmanagement 6 · name 1 · founded 1 · ownership 2
- ManagementJarne Elleholm appointed chair of the board
- ManagementBenedicte Francoise Simone Flambard appointed board member
- ManagementKenneth Veland Halberg appointed board member
- ManagementEva Maria Rebrova appointed board member
- NameName changed from NanoGuard Crop Solutions ApS to Yngvi Bio ApS
- FoundedRegistered as NanoGuard Crop Solutions ApS
- ManagementKenneth Veland Halberg appointed director
- ManagementEva Maria Rebrova appointed director
- OwnershipVeland Halberg Holding ApS registered as owner (50%)
- OwnershipEvaNova Holding ApS registered as owner (50%)
Related companies
Same industry in København
- Genmab A/S676 employees
- 3shape A/S518 employees
- Carlsberg A/S107 employees
- IQVIA RDS Denmark A/S100 employees
- Nuevolution A/S100 employees
- Sunshine Enterprise Holding A/S73 employees
Same people in management
- Cheminova A/Svia Benedicte Francoise Simone Flambard
- Rsp Systems A/Svia Jarne Elleholm
- Noscomed Medical Supply A/Svia Benedicte Francoise Simone Flambard
- EvodiaBio ApSvia Jarne Elleholm
- Chromologics ApSvia Jarne Elleholm
- Alontia A/Svia Jarne Elleholm
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.